Navigation Links
INTERCIM Received a New Patent for a Non-statistical Approach for "Design of Experiments" and the Iterative Discovery of an Explanatory Model
Date:10/6/2010

Discovery of an Explanatory Model    

Company Awarded Patent # 7,617,171 B2

ST. PAUL, Minnesota and PARIS, October 6, 2010 /PRNewswire/ -- Intercim, LLC, a global leader in manufacturing operation management (MOM) software, announced it has been awarded a patent called "Process for the iterative construction of an explanatory model".

This patented process is a key component of the Intercim Operations Intelligence technology and will help industrial manufacturers and life sciences researchers in two ways: unlike a statistics-based approach, it reuses existing information to optimize the length and cost of an experiment plan and it gives a quick and effective way to confirm the reliability of a discovery with only a few experiments.

This approach enables Pertinence Suite's users to get, much faster, a more reliable explanatory model even with limited data points available in a highly multi-dimensional non-euclidian space.

"This approach seems much easier to adopt than other standard Design of Experiment techniques, because we can analyze simultaneously the influence of many design parameters without statistical hypotheses. Thanks to the Interactive Experiment Planning of Process Rule Discovery(TM), we have reduced our need for physical experiments by 50% and sometimes more," says Dominique Veret, former Head of Development at Siemens Automotive Hydraulics, now Continental.

In the last 18 months, Intercim has received several additional patents which validate the uniqueness of Intercim's logic-based analytics for rule discovery and rule-based real-time predictions on complex systems and industrial processes. The announcement of this latest patent further demonstrates the unprecedented value proposition that Intercim offers to the market in terms of Operations Intelligence. John Todd, Intercim's CEO adds, "This patent confirms that Intercim truly offers a unique and high value-ad
'/>"/>

SOURCE Intercim
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. ITGI Medical Received a CE Mark for its Second Pericardium Covered Stent - AneuGraft(R) - for Tortuous Vessels
2. MIT is pleased to announce that it has received a US$ 500,000 private placement from its Chinese partners
3. MIT is pleased to announce that it has received clearance by FINRA to be listed on the OTC Bulletin Board "MDLH.OB"
4. MADIT-CRT Trial Data Show Women Received Greater Benefit From CRT-Ds Than Men
5. Aeterna Zentaris Announces Perifosine Has Received Orphan-Drug Designation for the Treatment of Neuroblastoma
6. Bion Announces Approval of New U.S. Patent for Phosphorus Removal Process for Livestock Waste Environmental Treatment
7. Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)
8. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for Cancer Therapy Based on Targeting a Biomarker by Novel Investigational Agents
9. Ortho-McNeil Neurologics to Appeal Patent Ruling on RAZADYNE(R)
10. PSKW Expands Its Lawsuit Against McKesson to Seek Assignment of McKessons Patent Application
11. Purdue Pharma L.P. Announces Resolution of OxyContin(R) Patent Lawsuit with Mallinckrodt Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 2015 Research and Markets ( ... "Clinical Laboratory, Molecular Diagnostics and Genomic Testing ... - Global Version" report to their offering. ... area of molecular diagnostics and pharmacogenics hold the ... market that is moving out of the national ...
(Date:5/5/2015)... , May 5, 2015 CytomX, a ... cancer, today announced that Sean McCarthy , D. ... Suisse Antibody Day in New York ... Dr. McCarthy will present an overview of CytomX,s Probody ... drug conjugate programs. About CytomX Therapeutics ...
(Date:5/5/2015)... 5, 2015   Tocagen Inc. , a ... R. Parkinson , M.D., a venture partner at ... the board of directors of Tocagen. Dr. Parkinson ... oncology clinical development, including leading clinical activities at ... of the cancer therapeutics Gleevec®, Femara®, Zometa®, Kepivance® ...
(Date:5/5/2015)... GEA Pharma Systems, G-CON Manufacturing ... of the INTERPHEX Exhibitor Awards for 2015 for ... Continuous, Miniature and Modular (PCMM) platform. PCMM comprises ... processing equipment, smart control systems and PODs (portable, ... inactive ingredients into bulk tablets. , PCMM ...
Breaking Biology Technology:Global Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecast 2015 to 2019 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 3Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 4GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 2GEA Pharma Systems, G-CON Manufacturing and Pfizer Consortium Receives Best Technology Innovation Award at INTERPHEX 2015 3
... For the second time this year, a tech-based company in ... to the public. Called an initial public offering, this kind ... and investors who are directly involved, but to others who ... Madison-based biotechnology company, has filed papers with the Securities ...
... rates of failure. As a result, many organizations are ... result stifles innovation, growth, and a company's competitive advantage. ... flawed processes of yesterday, and introducing methods that create ... delivery of functional software. , , Evidence , ...
... - Now that two companies he once owned have ... Brian Wiegand's days as a self-described serial entrepreneur might ... NameProtect , a developer of digital brand management services, ... of Wilmington, Del. , ,He will concentrate on growing ...
Cached Biology Technology:Wisconsin IPOs are a harbinger of growing tech economy 2Wisconsin IPOs are a harbinger of growing tech economy 3Agile Revolution: A new era of software delivery 2Agile Revolution: A new era of software delivery 3Agile Revolution: A new era of software delivery 4NameProtect sold, tech entrepreneur to focus on Jellyfish.com 2
(Date:4/10/2015)... April 10, 2015 Research and ... the "Security Competitive Profiles - NEC" report ... NEC will continue to supply a range ... market, with a company focus on the development of ... Winning opportunities in the Asia-Pacific ...
(Date:4/6/2015)... Conn. , Apr. 6, 2015 NXT-ID, ... "Company"), a biometric authentication company focused on the ... has filed provisional patent 62/143028 for ... COMMUNICATIONS AND ENERGY TRANSFER  NXT-ID introduces a ... payments. This patent surrounds the use of miniature ...
(Date:4/2/2015)... Sweden , April 2, 2015 ... for Q1 2015 attributed to somewhat higher than 125 ... in the year-end report 2014 that revenues for Q1 ... that the company reported for Q4 2014. The operating ... to be negative. The complete interim report will as ...
Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4Fingerprint Cards Revises Revenues for Q1 2015 2
... of Adelaide reproductive biologist has achieved a major breakthrough ... of women around the world who have suffered previous ... NHMRC Principal Research Fellow and member of the University,s ... develop a product which improves IVF embryo implantation rates ...
... (Jan. 5, 2011) The number of women who ... 59 percent over the last two decades thanks to ... recent study. The report,s lead researcher, Joy Hawkins, ... at the University of Colorado School of Medicine, said ...
... St. Louis, MO, January 6, 2011 Thanks to the ... statistics like 1 in 4 children are obese and childhood ... With this platform, nutrition education and physical activity in the ... study in the January/February 2011 issue of the Journal ...
Cached Biology News:IVF breakthrough to hit the world market 2Deaths from anesthesia during childbirth plummet 2School-based interventions for obesity 2
... The Fujifilm Life Science LAS-3000 ... technology with a simplified user interface, ... a wide range of modularities. The ... for a wide range of applications ...
The LAS-3000 imaging system combines new CCD camera technology with a simplified user interface to provide significantly improved system sensitivity with a wide range of modularities. This system is...
Capture faint-light images without losing sensitivity or resolution. With its brand new hardware and interface design, the LAS-1000plus turns sample imaging into a simple process....
Designed for use with the Agencourt CleanSEQ and Agencourt AMPure 384-well SPRI reagent kits. For use with 384-well thermal cycling plates....
Biology Products: